Company Filing History:
Years Active: 2001
Title: Klasu Muhlegger: Innovator in Antiviral Pharmaceutical Agents
Introduction
Klasu Muhlegger is a notable inventor based in Polling, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Klasu Muhlegger holds a patent for "Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity." This patent describes oligodeoxyribonucleotides in which at least two 2′-deoxy-β-D-erythro-pentofuranosyl groups are replaced by 2′-deoxy-β-D-threo-pentofuranosyl groups at both the 5′ end and 3′ end. Additionally, it covers oligodeoxyribonucleotides where at least 20% of the 2′-deoxy-β-D-erythro-pentofuranosyl groups in consecutive nucleotide building blocks are replaced by 2′-deoxy-β-D-threo-pentofuranosyl groups. These compounds, composed of 6 to 100 nucleotide building blocks, are suitable for inhibiting the expression of viral genes and oncogenes through the antisense principle, making them valuable for the production of pharmaceutical agents with antiviral activity. Klasu has 1 patent to her name.
Career Highlights
Klasu Muhlegger is currently employed at Roche Diagnostics GmbH, a leading company in the field of diagnostics and pharmaceuticals. Her role at Roche allows her to apply her innovative ideas and contribute to the development of cutting-edge medical solutions.
Collaborations
Throughout her career, Klasu has collaborated with esteemed colleagues, including Herbert Von Der Eltz and Frank Seela. These collaborations have further enriched her research and development efforts, leading to advancements in antiviral therapies.
Conclusion
Klasu Muhlegger is a pioneering inventor whose work in antiviral pharmaceutical agents has the potential to make a significant impact on healthcare. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement.